We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
-6.99%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
AUM
$309M
AUM Growth
+$9.64M
Cap. Flow
+$29.4M
Cap. Flow %
9.51%
Top 10 Hldgs %
36.34%
Holding
93
New
15
Increased
35
Reduced
30
Closed
7

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$4.58M
2
ABBV icon
AbbVie
ABBV
+$4.49M
3
MDT icon
Medtronic
MDT
+$4.43M
4
ZBH icon
Zimmer Biomet
ZBH
+$3.96M
5
ABT icon
Abbott
ABT
+$3.76M

Sector Composition

Rank Sector Weight
1 Healthcare 83.88%
2 Financials 3.47%
3 Industrials 1.36%
4 Technology 0.14%
5 Consumer Staples 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
76
AbbVie
ABBV
$434B
$383K 0.12%
6,700
-80,600
-92% -$4.49M
DPLO
77
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$378K 0.12%
+13,800
New +$406K
WOOF
78
DELISTED
VCA Inc.
WOOF
$363K 0.12%
+6,300
New +$327K
BHC icon
79
Bausch Health
BHC
$2.51B
$355K 0.12%
13,500
+5,700
+73% +$422K
DERM
80
DELISTED
Dermira, Inc.
DERM
$273K 0.09%
13,188
CI icon
81
Cigna
CI
$73.8B
$256K 0.08%
1,866
-19,554
-91% -$2.69M
ZLTQ
82
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$247K 0.08%
9,100
-49,000
-84% -$1.16M
XENT
83
DELISTED
Intersect ENT, Inc
XENT
$228K 0.07%
12,000
-28,000
-70% -$507K
ALPN
84
DELISTED
Alpine Immune Sciences Inc
ALPN
$129K 0.04%
7,746
TRIL
85
DELISTED
Trillium Therapeutics Inc.
TRIL
$116K 0.04%
12,500
ACAD icon
86
Acadia Pharmaceuticals
ACAD
$4.41B
-10,010
Closed -$357K
JNJ icon
87
Johnson & Johnson
JNJ
$607B
-5,800
Closed -$596K
PTCT icon
88
PTC Therapeutics
PTCT
$5.7B
-14,800
Closed -$480K
REGN icon
89
Regeneron Pharmaceuticals
REGN
$78.5B
-746
Closed -$405K
HMSY
90
DELISTED
HMS Holdings Corp.
HMSY
-85,163
Closed -$1.05M
WCG
91
DELISTED
Wellcare Health Plans, Inc.
WCG
-4,604
Closed -$360K
BDSI
92
DELISTED
BioDelivery Sciences International, Inc.
BDSI
-278,380
Closed -$1.33M

Similar funds

Endurant Capital Management's Q1 2016 Portfolio in Review

As of Q1 2016, Endurant Capital Management held 93 positions worth $309M, up 3.2% from $299M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Endurant Capital Management deployed $29.4M of net new capital in Q1 2016, opening 15 new positions and adding to 35 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 119,706 shares worth $7.31M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Viatris, an estimated $4.58M trimmed.

  • Endurant Capital Management's largest Q1 2016 buy was Envision Healthcare Holdings Inc: 119,706 shares worth $7.31M.
  • Endurant Capital Management added most to HILL-ROM HOLDINGS, INC. in Q1 2016, an estimated $6.46M increase.
  • Endurant Capital Management's biggest Q1 2016 reduction was Viatris, cutting an estimated $4.58M.
  • Endurant Capital Management fully exited BioDelivery Sciences International, Inc. in Q1 2016, selling an estimated $1.33M.
  • Endurant Capital Management's ten largest holdings make up 36% of its $309M portfolio in Q1 2016.
  • Endurant Capital Management opened 15 new positions and closed 7 in Q1 2016.
  • Endurant Capital Management's portfolio value rose 3.2% quarter-over-quarter to $309M.

Based on Endurant Capital Management's 13F filing for Q1 2016, filed 16 May 2016.